RESUMO
Pulmonary hypertension (PH) is a devastating condition that without proper management can deteriorate progressively. Elevated pulmonary artery pressure without an identifiable etiology is called IPAH. PH resulting from a specific disease is referred to as secondary PH; left-sided cardiac disease can lead to an increase in pulmonary artery pressure resulting in increased vascular resistance and subsequent structural remodeling. If left-sided failure progresses to right-sided failure with high pulmonary artery pressure, the outcome is ominous. It has been clearly proven that early diagnosis and effective medical therapy can markedly decrease morbidity and mortality. In this review, we discuss the current treatment modalities and their limitations for PH secondary to heart failure. Conventional therapy in patients with pulmonary arterial hypertension as well as recent advances in the medical management of PH in general, are also described. Last, the surgical management of these patients and other promising interventional modalities are reviewed.
Assuntos
Insuficiência Cardíaca/complicações , Hipertensão Pulmonar/terapia , Animais , Diagnóstico Diferencial , Diagnóstico Precoce , Humanos , Hipertensão Pulmonar/classificação , Hipertensão Pulmonar/etiologia , Hipertensão Pulmonar/fisiopatologia , Pulmão/irrigação sanguíneaRESUMO
A G2 inferior vena cava (IVC) filter was discovered in the right ventricle of an asymptomatic patient 3 months after placement. The present report describes an endovascular approach to remove the filter with use of two 35-mm Amplatz Goose Neck snares while the patient's cardiac rhythm was monitored and controlled by a cardiothoracic anesthesiologist.